Drug intelligence / Profile preview

NCTF 135 HA

Development stage
Unknown
Lead developer
FILLMED
Administration
Injection (intradermal, Mesotherapy/intradermal Microinjection)
01

Overview

**NCTF 135 HA** is a sterile, injectable polyrevitalizing solution developed for mesotherapy and aesthetic indications. It contains non-crosslinked hyaluronic acid (5 mg/mL) combined with a blend of 59 active ingredients, including vitamins, amino acids, minerals, nucleotides, coenzymes, and antioxidants. Designed for injection into the dermis of the face, neck, and décolleté, its primary purpose is to deliver hydration, promote skin redensification, improve skin radiance, texture, and elasticity, and reduce superficial wrinkles associated with aging. Hyaluronic acid acts to hydrate and plump skin, while the cocktail of nutrients stimulates collagen and elastin synthesis, promotes cell regeneration, protects against oxidative stress, and supports the extracellular matrix. NCTF 135 HA is considered a first-generation skin booster and mesotherapy agent, with clinically demonstrated efficacy in wrinkle reduction, increased skin hydration, and improvements in skin density and self-esteem. It is not indicated for disease treatment, but for cosmetic and anti-aging skin revitalization in adults over 18 years[1][2][3][4][5][6][7].

Brand names
NCTF 135 HANCTF135 HANCTF-135 HA
Other names
NCTF135HANCTF-135HANCTF 135HA

Beyond the preview

Go deeper on NCTF 135 HA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NCTF 135 HA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call